<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04092387</url>
  </required_header>
  <id_info>
    <org_study_id>CHRMS19-0129</org_study_id>
    <secondary_id>U54DA036114-06</secondary_id>
    <nct_id>NCT04092387</nct_id>
  </id_info>
  <brief_title>Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age</brief_title>
  <official_title>Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vermont</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Food and Drug Administration (FDA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Vermont</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite marked reductions in cigarette smoking in the general population, smoking rates among
      economically disadvantaged women have increased. Smoking among women of reproductive age is a
      particular concern because in addition to the usual health risks, there are additional risks
      should they become pregnant. A national nicotine reduction policy for cigarettes has
      considerable potential to reduce tobacco use, dependence, and improve health in these
      smokers. Controlled trials in general population samples have demonstrated that reducing the
      nicotine content in cigarettes can reduce cigarettes per day (CPD), dependence severity, and
      tobacco toxicant exposure.

      The goal of the proposed trial is to experimentally examine whether increasing the
      availability and appeal of an alternative, non-combusted source of nicotine (e-cigarettes)
      moderates the effects of altering the nicotine in cigarettes in non-pregnant female cigarette
      smokers of childbearing age. Additionally, investigators will test whether allowing
      participants to personalize the flavor of the e-liquid alters any moderating effects their
      availability may have on tobacco cigarette smoking.

      Daily smokers who are female, aged 18-44 years, and have a maximum educational attainment of
      graduating high school, will be recruited at Johns Hopkins University and the University of
      Vermont.

      Investigators will study two research cigarettes referred to here as Research Cigarettes 1
      (RC1) and Research Cigarettes 2 (RC2). One of these cigarettes will be a normal nicotine
      content cigarette and the other will be a reduced nicotine content cigarette. Investigators
      will study two e-cigarette conditions referred to here as E-Cigarette Condition 1 (EC1) and
      E-Cigarette Condition 2 (EC2). Both e-cigarette conditions will involve the same commercially
      available devices and same nicotine-containing e-liquid, but in one condition that e-liquid
      will be available only in tobacco flavor while in the other condition that e-liquid will be
      available in multiple flavors from which participants can choose based on personal taste
      preference. Participants will be assigned to one of the following four study conditions: (1)
      RC1 only; (2) RC2 only; (3) RC2 + EC1; (4) RC2 + EC2.

      Participants will be asked to use only their assigned study products for 16 weeks. Outcome
      measures include total CPD, cigarette demand assessed by behavioral economics-based purchase
      tasks, craving, withdrawal, psychiatric symptoms, breath carbon monoxide (CO), biomarkers of
      tobacco toxicant exposure, brain function and structure, and airway inflammation (fractional
      nitric oxide concentration in exhaled breath [FeNO]).
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    COVID19 pandemic
  </why_stopped>
  <start_date type="Actual">September 18, 2019</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double blind dosing of tobacco cigarette nicotine levels.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Cigarettes Smoked Per Day</measure>
    <time_frame>16 weeks</time_frame>
    <description>Cigarettes per day will be assessed for use of cigarettes with different nicotine content.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">246</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>RC 1 only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Research cigarettes #1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RC 2 only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Research Cigarettes #2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RC 2 + EC 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Research Cigarettes #2 plus E-cigarettes #1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RC 2 + EC 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Research Cigarettes #2 plus E-cigarettes #2</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cigarettes with varying nicotine content</intervention_name>
    <description>1) Altering the nicotine content of the tobacco research cigarettes</description>
    <arm_group_label>RC 1 only</arm_group_label>
    <arm_group_label>RC 2 + EC 1</arm_group_label>
    <arm_group_label>RC 2 + EC 2</arm_group_label>
    <arm_group_label>RC 2 only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>E-Cigarettes</intervention_name>
    <description>1) Altering the availability of e-cigarettes; 2) Altering option to personalize the e-liquid in the e-cig conditions</description>
    <arm_group_label>RC 2 + EC 1</arm_group_label>
    <arm_group_label>RC 2 + EC 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  21 to 44 years old

        Exclusion Criteria:

          -  Male

          -  Under 21 years old

          -  Over 44 years old
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Participants must be female.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen T. Higgins, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Vermont</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Vermont</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 13, 2019</study_first_submitted>
  <study_first_submitted_qc>September 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2019</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vermont</investigator_affiliation>
    <investigator_full_name>Stephen T. Higgins, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Biomarkers of Exposure</keyword>
  <keyword>Compensatory Smoking</keyword>
  <keyword>Nicotine Dependence</keyword>
  <keyword>Reduced Nicotine Cigarettes</keyword>
  <keyword>Tobacco Withdrawal</keyword>
  <keyword>Women</keyword>
  <keyword>Health Disparities</keyword>
  <keyword>Vulnerable Populations</keyword>
  <keyword>E-Cigarettes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

